BSECompany Update1d ago · 6 Aug 2026, 06:27 pm

Additional Details Required for Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations, 2015

Amrutanjan Health Care Ltd-$ · 590006

✦ AI SummaryRegulatory

Amrutanjan Health Care Ltd has filed an additional explanation for a corporate announcement under Regulation 30 of SEBI (LODR) Regulations, 2015, regarding a credit rating received from Care Ratings Limited, citing unavoidable circumstances due to the unavailability of the KMP and a need to maintain governance standards.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Amrutanjan Health Care Ltd-$ - 590006 - Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015,

Attachments (1)

📄

925699d4-5b0c-413d-8faa-72de27560f3b.pdf

pdf

Download →
View document text
6 August 2026 BSE Limited Department of Corporate Services, 1st Floor, P.J. Towers, Dalal Street, Mumbai 400 001 Scrip Code: 590006 Dear Sir/ Madam, Sub.: Additional Details Required for Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations, 2015, vide your email dated 6 August 2026 Ref.: Intimation filed under Regulation 30 SEBI (LODR)-Credit Rating dated 5 August 2026. This is with reference to the intimation filed under Regulation 30 of SEBI (LODR) Regulations, 2015 dated 5 August 2026, regarding the Credit Rating received from Care Ratings Limited. In this regard, we respectfully submit the following facts explaining the unavoidable circumstances that led to this inadvertent delay. The KMP was unexpectedly unavailable due to sudden travel with no access to secure corporate systems. To maintain Governance standards and prevent any incomplete or inaccurate market dissemination, the Compliance team was required to wait for the formal review and authorization from the KMP before executing the regulatory submissions on the portal. We hereby confirm that no price sensitive information was revealed. During the period, the trading window for dealing in the securities of the Company was closed for all Designated Persons. Consequently, there was no possibility of selective misuse of this information. In light of our good compliance record, we humbly request the Exchange to take this explanation on record and condone the inadvertent delay. We assure to maintain the highest standards of corporate governance, as always, and ensure timely compliance with all applicable Stock Exchange intimation and disclosure requirements. Thanking You, Yours faithfully For Amrutanjan Health Care Limited (Gagan Preet Singh) General Manager - Legal Company Secretary & Compliance Officer Amrutanjan Health Care Limited I 03, (Old No. 42-45), Luz Church Road, E-mail :customercare@amrutanjan.com Mylapore, Chennai - 600 004 WebSite : www. amrutanjan.com Tamil Nadu, India. Toll Free No.: I • 800 - 425 - 4545 Tel :+91-44 - 2499 4465 CIN-L24231TN1936PLC000017 +91-44 • 2466 9000 Fax :+91-44 - 2499 4585